Impaired NK-cell distribution with a phenotypic shift from a mature to immature state along with an impaired NK antitumor response in relation to the inhibitory CD159a expression has been previously demonstrated in patients with MDS and AML. This evidence concerns the gene KLRC1 and acute myeloid leukemia.